Predicting testosterone decline in middle-aged men
Part of Brain & nervous system, Hormones & metabolism, Mental health clinical trials.
This study looks at why testosterone levels drop in men aged 35-59. It may help identify early signs and ways to prevent it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 35 and 59 years old
- You live in the Andijan region of Uzbekistan
- You can understand the study and agree to take part
- You are willing to have physical exams, body measurements, and lab tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at factors in the body that may affect male fertility in men who have trouble getting someone pregnant. You may be asked about your health history, and it may help researchers understand what changes could improve fertility—especially when hormone levels are low.
This study examines how testosterone therapy affects blood pressure in men with low testosterone. It uses a 24-hour blood pressure monitor to track changes over time.
This study looks at how men with low testosterone (hypogonadism) feel about stigma, their sense of self, and their quality of life. It aims to understand these experiences better so that care can be improved.
This study tests whether a special diet can improve symptoms of low testosterone in men. It is intended to help men with certain symptoms like a low sex drive or trouble having erections and whose blood tests show low to borderline testosterone levels.
This study tests whether testosterone therapy helps older men over 70 who are weak or frail and have naturally low testosterone levels. Researchers want to see if it improves strength, walking ability, and overall health.
This trial tests a testosterone injection (XYOSTED) to see if it's safe and effective for replacing testosterone in teenage boys who have low levels due to a known medical condition. It lasts 52 weeks, with an optional 2-year follow-up.
Hear when a new Testosterone Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.